We designed our approach, our structure and our focus around gathering valid independent insights to deliver high value commercial intelligence that informs successful strategy and tactics.
Covering Chronic Kidney Disease, Dialysis, Diabetic Nephropathy, Hyperkalemia, Hyperphosphatemia, Renal Anemia, SHPT and Lupus Nephritis.
Wide array of common autoimmune conditions (RA, PsA, Psoriasis, IBD, Atopic dermatitis) and rare conditions (GCA, Systemic Sclerosis, SLE, Vasculitis).
In-depth analysis of the Multiple Sclerosis market.
An emphasis on rare pulmonary diseases including Idiopathic Pulmonary Fibrosis (IPF) and Pulmonary Arterial Hypertension (PAH).
Retrospective analysis of 1,000 patient charts
Rapid turnaround monitor for highly dynamic segments
Forward looking assessment of markets with lots of development activity
An audit of the patients that pass through a specialist’s clinic
Capturing the patient perspective
Understanding tomorrow’s specialists